Quidel Corp
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Beaten down at the start of the quarter, as health stocks generally are punished
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move to the down side
- Buy at oversold position on RSI (now)
- Expectation for the price to move to TARGET RANGE during the financial quarter
- Trailing stop-loss on price above TARGET PRICE
GOOD LUCK.
DO YOUR OWN RESEARCH!
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Beaten down at the start of the quarter, as health stocks generally are punished
Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move to the down side
- Buy at oversold position on RSI (now)
- Expectation for the price to move to TARGET RANGE during the financial quarter
- Trailing stop-loss on price above TARGET PRICE
GOOD LUCK.
DO YOUR OWN RESEARCH!
Riding to quarter end for potential break-even